Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 10/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 10/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 3/20 | 0.32 |
| ▸ | TMPRSS6 | Q8IU80 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.32 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7417980 | 0.92 | MEN1 (0.40) | MEN1KMT2AITGB3ITGA2BPOLB | |
| Trifluoroacetic Acid SCHEMBL7412868 | 0.90 | ITGB3 (0.47) | MEN1KMT2AITGB3ITGA2BITGB1 | |
| SCHEMBL7414783 | 0.89 | CYP3A4 (0.43) | MEN1KMT2AITGB3ITGA2BPOLB | |
| SCHEMBL7416202 | 0.89 | MEN1 (0.38) | MEN1KMT2AITGB3ITGA2BPOLB | |
| SCHEMBL7415446 | 0.89 | ITGB3 (0.39) | MEN1KMT2AITGB3ITGA2BPOLB | |
| SCHEMBL7408394 | 0.88 | ITGB3 (0.37) | ITGB3ITGA2BF2TMPRSS6CYP3A4 | |
| SCHEMBL7410416 | 0.88 | L3MBTL1 (0.41) | KMT2AITGB3ITGA2BF2TMPRSS6 | |
| SCHEMBL7412629 | 0.87 | CTSL (0.43) | ITGB3ITGA2BF2TMPRSS6 | |
| SCHEMBL7414225 | 0.87 | ITGB3 (0.50) | MEN1KMT2AITGB3ITGA2BPOLB | |
| SCHEMBL7418586 | 0.87 | CYP3A4 (0.41) | ITGB3ITGA2BF2TMPRSS6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6344484-B1 | TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-02-05 | — | — | US | disclosed |
| EP-1159262-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000047552-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | disclosed |